Cargando…
Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483363/ https://www.ncbi.nlm.nih.gov/pubmed/36794507 http://dx.doi.org/10.3324/haematol.2022.282596 |
| _version_ | 1785102362571964416 |
|---|---|
| author | Vignal, Nicolas Kelly, Loïs Lengline, Etienne Cabannes-Hamy, Aurélie Siavellis, Justine Ghez, David Sauvageon, Hélène Braun, Thorsten Jacqz-Aigrain, Evelyne Kohn, Milena Rousselot, Philippe Puissant, Alexandre Raffoux, Emmanuel Mourah, Samia Goldwirt, Lauriane |
| author_facet | Vignal, Nicolas Kelly, Loïs Lengline, Etienne Cabannes-Hamy, Aurélie Siavellis, Justine Ghez, David Sauvageon, Hélène Braun, Thorsten Jacqz-Aigrain, Evelyne Kohn, Milena Rousselot, Philippe Puissant, Alexandre Raffoux, Emmanuel Mourah, Samia Goldwirt, Lauriane |
| author_sort | Vignal, Nicolas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10483363 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104833632023-09-08 Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients Vignal, Nicolas Kelly, Loïs Lengline, Etienne Cabannes-Hamy, Aurélie Siavellis, Justine Ghez, David Sauvageon, Hélène Braun, Thorsten Jacqz-Aigrain, Evelyne Kohn, Milena Rousselot, Philippe Puissant, Alexandre Raffoux, Emmanuel Mourah, Samia Goldwirt, Lauriane Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-02-16 /pmc/articles/PMC10483363/ /pubmed/36794507 http://dx.doi.org/10.3324/haematol.2022.282596 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Vignal, Nicolas Kelly, Loïs Lengline, Etienne Cabannes-Hamy, Aurélie Siavellis, Justine Ghez, David Sauvageon, Hélène Braun, Thorsten Jacqz-Aigrain, Evelyne Kohn, Milena Rousselot, Philippe Puissant, Alexandre Raffoux, Emmanuel Mourah, Samia Goldwirt, Lauriane Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients |
| title | Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients |
| title_full | Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients |
| title_fullStr | Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients |
| title_full_unstemmed | Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients |
| title_short | Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients |
| title_sort | favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia flt3-itd patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483363/ https://www.ncbi.nlm.nih.gov/pubmed/36794507 http://dx.doi.org/10.3324/haematol.2022.282596 |
| work_keys_str_mv | AT vignalnicolas favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT kellylois favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT lenglineetienne favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT cabanneshamyaurelie favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT siavellisjustine favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT ghezdavid favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT sauvageonhelene favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT braunthorsten favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT jacqzaigrainevelyne favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT kohnmilena favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT rousselotphilippe favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT puissantalexandre favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT raffouxemmanuel favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT mourahsamia favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients AT goldwirtlauriane favorablepharmacokineticandpharmacodynamicpropertiesofgilteritinibincerebrospinalfluidapotentialeffectivetreatmentinrelapsingmeningealacutemyeloidleukemiaflt3itdpatients |